Literature DB >> 31980993

The Power of the Shared Experience: MTN-020/ASPIRE Trial Participants' Descriptions of Peer Influence on Acceptability of and Adherence to the Dapivirine Vaginal Ring for HIV Prevention.

Ariana W K Katz1, K Naidoo2, K Reddy3, M Chitukuta4, J Nabukeera5, S Siva6, C Zimba7, E T Montgomery8.   

Abstract

Women are disproportionately at risk of acquiring HIV in East and Southern Africa, despite global declines in incidence. Female-initiated HIV prevention methods, like the dapivirine vaginal ring, are needed to end the HIV epidemic. In-depth interviews and focus groups retrospectively explored peer influence on acceptability of and adherence to the ring during the ASPIRE trial, a phase III placebo-controlled trial. Results were analyzed using an inductive analytic approach. Study participants (peers) of all ages and adherence groups developed important interpersonal connections and reported being more open and honest with each other than with external peers or study staff. Study peers who knew each other prior to joining appeared to have a stronger influence on each other's adherence than peers who met in the study. External peers provided primarily negative input about the ring and study, which sometimes led to ring removals. Peers' influence on each other's behavior in both prosocial and detrimental manners could have repercussions on adherence to a biomedical intervention, and consequently, individual disease risk and clinical trial outcomes. Future ring demonstration and implementation studies could use peer networks to intentionally influence uptake and adherence to the ring.

Entities:  

Keywords:  Dapivirine ring; HIV prevention; Microbicides; Peer influence; Sub-Saharan Africa

Mesh:

Substances:

Year:  2020        PMID: 31980993      PMCID: PMC8631948          DOI: 10.1007/s10461-020-02799-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  44 in total

1.  Perception of peers' behaviour regarding sexual health decision making among female undergraduates in Anambra State, Nigeria.

Authors:  P I Okonkwo; A O Fatusi; A L Ilika
Journal:  Afr Health Sci       Date:  2005-06       Impact factor: 0.927

2.  Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results.

Authors:  Elizabeth T Montgomery; Jonathan Stadler; Sarita Naidoo; Ariana W K Katz; Nicole Laborde; Morgan Garcia; Krishnaveni Reddy; Leila E Mansoor; Juliane Etima; Chifundo Zimba; Miria Chitukuta; Lydia Soto-Torres
Journal:  AIDS       Date:  2018-07-17       Impact factor: 4.177

Review 3.  A systematic review of peer-supported interventions for health promotion and disease prevention.

Authors:  Rajeev Ramchand; Sangeeta C Ahluwalia; Lea Xenakis; Eric Apaydin; Laura Raaen; Geoffrey Grimm
Journal:  Prev Med       Date:  2017-06-08       Impact factor: 4.018

4.  Social influences on the sexual behavior of youth at risk for HIV exposure.

Authors:  D Romer; M Black; I Ricardo; S Feigelman; L Kaljee; J Galbraith; R Nesbit; R C Hornik; B Stanton
Journal:  Am J Public Health       Date:  1994-06       Impact factor: 9.308

5.  Women's social communication about IUDs: a qualitative analysis.

Authors:  Nora Anderson; Jody Steinauer; Thomas Valente; Jenna Koblentz; Christine Dehlendorf
Journal:  Perspect Sex Reprod Health       Date:  2014-06-03

6.  Disclosure of pharmacokinetic drug results to understand nonadherence.

Authors:  Ariane van der Straten; Elizabeth T Montgomery; Petina Musara; Juliane Etima; Sarita Naidoo; Nicole Laborde; Miriam Hartmann; Lisa Levy; Thola Bennie; Helen Cheng; Jeanna Piper; Cynthia I Grossman; Jeanne Marrazzo; Barbara Mensch
Journal:  AIDS       Date:  2015-10-23       Impact factor: 4.177

Review 7.  Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials.

Authors:  K Rivet Amico; Leila E Mansoor; Amy Corneli; Kristine Torjesen; Ariane van der Straten
Journal:  AIDS Behav       Date:  2013-07

8.  Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention.

Authors:  Thesla Palanee-Phillips; Katie Schwartz; Elizabeth R Brown; Vaneshree Govender; Nyaradzo Mgodi; Flavia Matovu Kiweewa; Gonasagrie Nair; Felix Mhlanga; Samantha Siva; Linda-Gail Bekker; Nitesha Jeenarain; Zakir Gaffoor; Francis Martinson; Bonus Makanani; Sarita Naidoo; Arendevi Pather; Jessica Phillip; Marla J Husnik; Ariane van der Straten; Lydia Soto-Torres; Jared Baeten
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

9.  A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa.

Authors:  Amy L Corneli; Kevin McKenna; Jennifer Headley; Khatija Ahmed; Jacob Odhiambo; Joseph Skhosana; Meng Wang; Kawango Agot
Journal:  J Int AIDS Soc       Date:  2014-09-08       Impact factor: 5.396

10.  How can peer group influence the behavior of adolescents: explanatory model.

Authors:  Gina Tomé; Margarida Matos; Celeste Simões; José Alves Diniz; Inês Camacho
Journal:  Glob J Health Sci       Date:  2012-02-29
View more
  7 in total

1.  The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence.

Authors:  Marie C D Stoner; Elizabeth R Brown; Thesla Palanee-Phillips; Leila E Mansoor; Tchangani Tembo; Gonasagrie Nair; Carolyne Akello; Linly Seyama; Nitesha Jeenarain; Logashvari Naidoo; Nyaradzo Mgodi; Portia Hunidzarira; Miria Chitukuta; Ariane van der Straten
Journal:  AIDS Behav       Date:  2021-05-03

Review 2.  Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.

Authors:  Ignacio Rodríguez-Izquierdo; Daniel Sepúlveda-Crespo; Jose María Lasso; Salvador Resino; Ma Ángeles Muñoz-Fernández
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-12

3.  Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention.

Authors:  Krishnaveni Reddy; Florence Mathebula; Ariana Katz; Ellen Luecke; Siyanda Tenza; Thesla Palanee-Phillips; Morgan Garcia; Leila E Mansoor; Sarita Naidoo; Neetha Morar; Miria Chitukuta; Mercy Tsidya; Elizabeth T Montgomery
Journal:  AIDS Behav       Date:  2022-01-22

4.  Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial.

Authors:  Juliane Etima; Ariana W K Katz; Zoe Duby; Morgan Garcia; Thesla Palanee-Phillips; Krishnaveni Reddy; Florence Mathebula; Chifundo Zimba; Leila E Mansoor; Devika Singh; Elmah Manengamambo; Sarita Naidoo; Lydia Soto-Torres; Elizabeth T Montgomery
Journal:  AIDS Behav       Date:  2021-11-02

Review 5.  High Preventive Effect of G2-S16 Anionic Carbosilane Dendrimer against Sexually Transmitted HSV-2 Infection.

Authors:  Ignacio Rodriguez-Izquierdo; Samanta Gasco; Maria Angeles Muñoz-Fernández
Journal:  Molecules       Date:  2020-06-28       Impact factor: 4.411

Review 6.  Emergence of Nanotechnology to Fight HIV Sexual Transmission: The Trip of G2-S16 Polyanionic Carbosilane Dendrimer to Possible Pre-Clinical Trials.

Authors:  Ignacio Relaño-Rodríguez; Maria Ángeles Muñoz-Fernández
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

7.  Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial.

Authors:  Sarah T Roberts; Imogen Hawley; Ellen Luecke; Barbara Mensch; Theresa Wagner; Craig Hoesley; Tara McClure; Clara P Dominguez Islas; Jeanna M Piper; Albert Y Liu; Ariane van der Straten
Journal:  J Womens Health (Larchmt)       Date:  2021-10-19       Impact factor: 3.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.